Banca de DEFESA: GABRIELLA SANTOS BARROS

Uma banca de DEFESA de MESTRADO foi cadastrada pelo programa.
STUDENT : GABRIELLA SANTOS BARROS
DATE: 02/05/2022
TIME: 09:00
LOCAL: Vìdeoconferência
TITLE:

ANTIRETROVIRAL THERAPY COMPREHENSION: EDUCATIONAL PHARMACEUTICAL INTERVENTIONS AS A TOOL IN THE CARE OF HIV/AIDS PATIENTS IN THE STATE OF ALAGOAS

KEY WORDS:

Patient knowledge about the drug; Antiretroviral therapy; Pharmaceutical interventions; Pharmaceutical care; HIV/AIDS.

PAGES: 72
BIG AREA: Ciências da Saúde
AREA: Farmácia
SUBÁREA: Análise e Controle de Medicamentos
SUMMARY:

Despite the great advances in antiretroviral therapy over time, to achieve success in clinical results it is necessary to effectively take the drugs, following what was prescribed by the health professional. However, for the patient to use the medication properly, all possible information must be provided, clearly, so that he understands the therapeutic plan to be followed. The pharmacist has a fundamental role in the correct use of drug, since at the time of dispensing, it is the last contact that the patient has with a health professional before starting their treatment. Thus, this study objective to verify the level of information of patients about their pharmacotherapy and implement educational pharmaceutical interventions about their knowledge about antiretroviral therapy. Therefore, a prospective interventionist quantitative study was carried out in two health services in the state of Alagoas. To verify the level of information that patients had about their antiretroviral drug therapy, was used the instrument validated by Raehl et al. (2002), and viral charge laboratory test results were used to measure adherence before and after pharmaceutical interventions. 32 patients were followed up by a clinical pharmacist during the 10 month period. From the results obtained, it was possible to observe that the level of understanding of antiretroviral information was considered insufficient for 76.50% (n=102) of patients (p<0.001). When asked about the name of the medication they used, most participants could not inform (78.43%). There was also a high rate of disagreement (87.25%) regarding the dose of the drug, and approximately half of the participants (53.92%) said they did not know if there was any type of interaction with food or if it could be administered close to meal times. However, the most knew the indication (97.06%) as well as the administration times (94.12%) of their medications. Finally, when analyzing the results of viral charge laboratory tests performed before and during pharmaceutical follow-up, it was possible to observe an increase in the number of participants with undetectable viral charge results (< 50 copies/mL) (from 56.25% to 93.75%) (n=32) in the group followed by the clinical pharmacist (p<0.01). The present study shows that the high proportion of patients with a low level of understanding reinforces the importance of the health team in transmitting information more clearly, identifying factors associated with low understanding and solving possible doubts in order to guarantee good therapeutic results. The interventions performed by the pharmacist were able to contribute to the improvement of adherence due to the reduction of the viral charge values for the followed patients. In addition, it reinforces the importance of the pharmacist's presence in the multidisciplinary team developing clinical activities, in promoting the rational use of medicament.

BANKING MEMBERS:
Interna - 1640070 - ELIANE APARECIDA CAMPESATTO
Externo à Instituição - ERILDO VICENTE MULLER - UEPG
Interna - 1547952 - EURICA ADELIA NOGUEIRA RIBEIRO